Byhealth Co., Ltd (SHE:300146)
11.92
+0.04 (0.34%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Tablet | 2.48B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tablet Growth | -2.55% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Capsule | 1.96B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Capsule Growth | 12.60% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Powder | 1.37B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Powder Growth | 22.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 3.59B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 46.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| China | 7.94B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 18.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Australia | 989.03M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Australia Growth | 22.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hong Kong and Others | 550.94M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hong Kong and Others Growth | 35.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Inter-segment Offset | -70.87M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Inter-segment Offset Growth | 10.01% |
Log In |
Log In |
Log In |
Log In | Upgrade
|